Sanara MedTech holds special shareholder meeting

• Sanara MedTech held a special shareholder meeting on Sept. 30, 2026 to vote on the proposed merger with MiMedx.
• Shareholders adopted the merger agreement, clearing the vote required for the transaction to proceed toward closing.
• A separate proposal to allow adjournment of the meeting to solicit additional proxies was not put to a vote.
• The merger has not yet closed; the companies are still waiting for the Hart-Scott-Rodino review period to expire on Oct. 15, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-105390), on October 01, 2026, and is solely responsible for the information contained therein.